4-[2-[3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile

Isavuconazole; LC-ESI-QFT; MS2; CE: 15%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 20%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 25%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 30%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 40%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 50%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 60%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 70%; R=15000; [M+H]+

Isavuconazole; LC-ESI-QFT; MS2; CE: 80%; R=15000; [M+H]+